{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:15:43Z","timestamp":1791224143574,"version":"4.1.0"},"reference-count":196,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,7]],"date-time":"2015-10-07T00:00:00Z","timestamp":1444176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,10,7]],"date-time":"2015-10-07T00:00:00Z","timestamp":1444176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25430057"],"award-info":[{"award-number":["25430057"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Japan foundation for Neuroscience and Mental Health"},{"name":"Mitsui Life Social Welfare Foundation"},{"name":"Tokyo Metropolitan Institute of Medical Science"},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS089622"],"award-info":[{"award-number":["NS089622"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001262","name":"National Parkinson Foundation","doi-asserted-by":"publisher","award":["NPF-UN203"],"award-info":[{"award-number":["NPF-UN203"]}],"id":[{"id":"10.13039\/100001262","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s00401-015-1485-1","type":"journal-article","created":{"date-parts":[[2015,10,7]],"date-time":"2015-10-07T07:43:43Z","timestamp":1444203823000},"page":"49-73","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":227,"title":["Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies"],"prefix":"10.1007","volume":"131","author":[{"given":"Toshiki","family":"Uchihara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit I.","family":"Giasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,7]]},"reference":[{"issue":"1","key":"1485_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1471-4159.2006.03731.x","volume":"97","author":"KJ Ahn","year":"2006","unstructured":"Ahn KJ, Paik SR, Chung KC, Kim J (2006) Amino acid sequence motifs and mechanistic features of the membrane translocation of alpha-synuclein. J Neurochem 97(1):265\u2013279","journal-title":"J Neurochem"},{"issue":"2","key":"1485_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/nen.0b013e3181633526","volume":"67","author":"I Alafuzoff","year":"2008","unstructured":"Alafuzoff I, Parkkinen L, Al-Sarraj S, Arzberger T, Bell J, Bodi I, Bogdanovic N, Budka H, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Kamphorst W, King A, Korkolopoulou P, Kovacs GG, Larionov S, Meyronet D, Monoranu C, Morris J, Parchi P, Patsouris E, Roggendorf W, Seilhean D, Streichenberger N, Thal DR, Kretzschmar H, BrainNet Europe C (2008) Assessment of alpha-synuclein pathology: a study of the BrainNet Europe Consortium. J Neuropathol Exp Neurol 67(2):125\u2013143. doi:\n                    10.1097\/nen.0b013e3181633526","journal-title":"J Neuropathol Exp Neurol"},{"issue":"40","key":"1485_CR3","doi-asserted-by":"publisher","first-page":"29739","DOI":"10.1074\/jbc.M600933200","volume":"281","author":"JP Anderson","year":"2006","unstructured":"Anderson JP, Walker DE, Goldstein JM, de Laat R, Banducci K, Caccavello RJ, Barbour R, Huang J, Kling K, Lee M, Diep L, Keim PS, Shen X, Chataway T, Schlossmacher MG, Seubert P, Schenk D, Sinha S, Gai WP, Chilcote TJ (2006) Phosphorylation of ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J Biol Chem 281(40):29739\u201329752. doi:\n                    10.1074\/jbc.M600933200","journal-title":"J Biol Chem"},{"issue":"5","key":"1485_CR4","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00401-012-1040-2","volume":"124","author":"DM Annerino","year":"2012","unstructured":"Annerino DM, Arshad S, Taylor GM, Adler CH, Beach TG, Greene JG (2012) Parkinson\u2019s disease is not associated with gastrointestinal myenteric ganglion neuron loss. Acta Neuropathol 124(5):665\u2013680. doi:\n                    10.1007\/s00401-012-1040-2","journal-title":"Acta Neuropathol"},{"issue":"6","key":"1485_CR5","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/mds.25421","volume":"28","author":"S Appel-Cresswell","year":"2013","unstructured":"Appel-Cresswell S, Vilarino-Guell C, Encarnacion M, Sherman H, Yu I, Shah B, Weir D, Thompson C, Szu-Tu C, Trinh J, Aasly JO, Rajput A, Rajput AH, Jon SA, Farrer MJ (2013) Alpha-synuclein p. H50Q, a novel pathogenic mutation for Parkinson\u2019s disease. Mov Disord 28(6):811\u2013813. doi:\n                    10.1002\/mds.25421","journal-title":"Mov Disord"},{"issue":"13","key":"1485_CR6","first-page":"59","volume":"101","author":"A Barbeau","year":"1969","unstructured":"Barbeau A (1969) L-dopa therapy in Parkinson\u2019s disease: a critical review of nine years\u2019 experience. Can Med Assoc J 101(13):59\u201368","journal-title":"Can Med Assoc J"},{"issue":"6","key":"1485_CR7","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","volume":"119","author":"TG Beach","year":"2010","unstructured":"Beach TG, Adler CH, Sue LI, Vedders L, Lue L, White Iii CL, Akiyama H, Caviness JN, Shill HA, Sabbagh MN, Walker DG, Arizona Parkinson\u2019s Disease C (2010) Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 119(6):689\u2013702. doi:\n                    10.1007\/s00401-010-0664-3","journal-title":"Acta Neuropathol"},{"issue":"3","key":"1485_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00401-008-0409-8","volume":"116","author":"TG Beach","year":"2008","unstructured":"Beach TG, White CL, Hamilton RL, Duda JE, Iwatsubo T, Dickson DW, Leverenz JB, Roncaroli F, Buttini M, Hladik CL, Sue LI, Noorigian JV, Adler CH (2008) Evaluation of alpha-synuclein immunohistochemical methods used by invited experts. Acta Neuropathol 116(3):277\u2013288. doi:\n                    10.1007\/s00401-008-0409-8","journal-title":"Acta Neuropathol"},{"issue":"2","key":"1485_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0006-8993(02)02830-5","volume":"946","author":"JM Beaulieu","year":"2002","unstructured":"Beaulieu JM, Kriz J, Julien JP (2002) Induction of peripherin expression in subsets of brain neurons after lesion injury or cerebral ischemia. Brain Res 946(2):153\u2013161","journal-title":"Brain Res"},{"key":"1485_CR10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.brainres.2011.11.031","volume":"1432","author":"A Bellucci","year":"2012","unstructured":"Bellucci A, Navarria L, Zaltieri M, Missale C, Spano P (2012) Alpha-synuclein synaptic pathology and its implications in the development of novel therapeutic approaches to cure Parkinson\u2019s disease. Brain Res 1432:95\u2013113. doi:\n                    10.1016\/j.brainres.2011.11.031","journal-title":"Brain Res"},{"issue":"5","key":"1485_CR11","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S1474-4422(13)70047-4","volume":"12","author":"D Berg","year":"2013","unstructured":"Berg D, Lang AE, Postuma RB, Maetzler W, Deuschl G, Gasser T, Siderowf A, Schapira AH, Oertel W, Obeso JA, Olanow CW, Poewe W, Stern M (2013) Changing the research criteria for the diagnosis of Parkinson\u2019s disease: obstacles and opportunities. Lancet Neurol 12(5):514\u2013524. doi:\n                    10.1016\/S1474-4422(13)70047-4","journal-title":"Lancet Neurol"},{"issue":"4","key":"1485_CR12","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/mds.25844","volume":"29","author":"D Berg","year":"2014","unstructured":"Berg D, Postuma RB, Bloem B, Chan P, Dubois B, Gasser T, Goetz CG, Halliday GM, Hardy J, Lang AE, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschl G (2014) Time to redefine PD? Introductory statement of the MDS task force on the definition of Parkinson\u2019s disease. Mov Disord 29(4):454\u2013462. doi:\n                    10.1002\/mds.25844","journal-title":"Mov Disord"},{"key":"1485_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/2051-5960-2-29","volume":"2","author":"D Betemps","year":"2014","unstructured":"Betemps D, Verchere J, Brot S, Morignat E, Bousset L, Gaillard D, Lakhdar L, Melki R, Baron T (2014) Alpha-synuclein spreading in M83 mice brain revealed by detection of pathological alpha-synuclein by enhanced elisa. Acta Neuropathol Commun 2:29. doi:\n                    10.1186\/2051-5960-2-29","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"1485_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.nbd.2012.05.018","volume":"48","author":"J Blesa","year":"2012","unstructured":"Blesa J, Pifl C, Sanchez-Gonzalez MA, Juri C, Garcia-Cabezas MA, Adanez R, Iglesias E, Collantes M, Penuelas I, Sanchez-Hernandez JJ, Rodriguez-Oroz MC, Avendano C, Hornykiewicz O, Cavada C, Obeso JA (2012) The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: a PET, histological and biochemical study. Neurobiol Dis 48(1):79\u201391. doi:\n                    10.1016\/j.nbd.2012.05.018","journal-title":"Neurobiol Dis"},{"issue":"3","key":"1485_CR15","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1365-2990.2006.00727.x","volume":"32","author":"A Bloch","year":"2006","unstructured":"Bloch A, Probst A, Bissig H, Adams H, Tolnay M (2006) Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects. Neuropathol Appl Neurobiol 32(3):284\u2013295. doi:\n                    10.1111\/j.1365-2990.2006.00727.x","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"8","key":"1485_CR16","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.sleep.2012.10.015","volume":"14","author":"BF Boeve","year":"2013","unstructured":"Boeve BF, Silber MH, Ferman TJ, Lin SC, Benarroch EE, Schmeichel AM, Ahlskog JE, Caselli RJ, Jacobson S, Sabbagh M, Adler C, Woodruff B, Beach TG, Iranzo A, Gelpi E, Santamaria J, Tolosa E, Singer C, Mash DC, Luca C, Arnulf I, Duyckaerts C, Schenck CH, Mahowald MW, Dauvilliers Y, Graff-Radford NR, Wszolek ZK, Parisi JE, Dugger B, Murray ME, Dickson DW (2013) Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med 14(8):754\u2013762. doi:\n                    10.1016\/j.sleep.2012.10.015","journal-title":"Sleep Med"},{"issue":"Pt 11","key":"1485_CR17","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1093\/brain\/awm056","volume":"130","author":"BF Boeve","year":"2007","unstructured":"Boeve BF, Silber MH, Saper CB, Ferman TJ, Dickson DW, Parisi JE, Benarroch EE, Ahlskog JE, Smith GE, Caselli RC, Tippman-Peikert M, Olson EJ, Lin SC, Young T, Wszolek Z, Schenck CH, Mahowald MW, Castillo PR, Del Tredici K, Braak H (2007) Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 130(Pt 11):2770\u20132788. doi:\n                    10.1093\/brain\/awm056","journal-title":"Brain"},{"issue":"12","key":"1485_CR18","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/mds.25135","volume":"27","author":"JP Bolam","year":"2012","unstructured":"Bolam JP, Pissadaki EK (2012) Living on the edge with too many mouths to feed: why dopamine neurons die. Mov Disord 27(12):1478\u20131483. doi:\n                    10.1002\/mds.25135","journal-title":"Mov Disord"},{"issue":"6","key":"1485_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1050-3862(96)00167-2","volume":"13","author":"DR Borchelt","year":"1996","unstructured":"Borchelt DR, Davis J, Fischer M, Lee MK, Slunt HH, Ratovitsky T, Regard J, Copeland NG, Jenkins NA, Sisodia SS, Price DL (1996) A vector for expressing foreign genes in the brains and hearts of transgenic mice. Genet Anal 13(6):159\u2013163","journal-title":"Genet Anal"},{"key":"1485_CR20","series-title":"Advances in anatomy, embryology and cell biology","volume-title":"Neuroanatomy and pathology of sporadic Parkinson\u2019s disease","author":"E Braak","year":"2009","unstructured":"Braak E, Del Tredici K (2009) Neuroanatomy and pathology of sporadic Parkinson\u2019s disease, vol 201., Advances in anatomy, embryology and cell biologySpringer, Berlin"},{"issue":"12","key":"1485_CR21","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1002\/mds.21065","volume":"21","author":"H Braak","year":"2006","unstructured":"Braak H, Bohl JR, M\u00fcller CM, R\u00fcb U, de Vos RA, Del Tredici K (2006) Stanley Fahn lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson\u2019s disease reconsidered. Mov Disord 21(12):2042\u20132051. doi:\n                    10.1002\/mds.21065","journal-title":"Mov Disord"},{"issue":"2","key":"1485_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24(2):197\u2013211","journal-title":"Neurobiol Aging"},{"issue":"4","key":"1485_CR23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00401-007-0193-x","volume":"113","author":"H Braak","year":"2007","unstructured":"Braak H, Sastre M, Bohl JR, de Vos RA, Del Tredici K (2007) Parkinson\u2019s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathol 113(4):421\u2013429. doi:\n                    10.1007\/s00401-007-0193-x","journal-title":"Acta Neuropathol"},{"issue":"2","key":"1485_CR24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1515\/revneuro-2011-0067","volume":"23","author":"SP Braithwaite","year":"2012","unstructured":"Braithwaite SP, Stock JB, Mouradian MM (2012) Alpha-synuclein phosphorylation as a therapeutic target in Parkinson\u2019s disease. Rev Neurosci 23(2):191\u2013198. doi:\n                    10.1515\/revneuro-2011-0067","journal-title":"Rev Neurosci"},{"issue":"10","key":"1485_CR25","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nrn2477","volume":"9","author":"P Brundin","year":"2008","unstructured":"Brundin P, Li JY, Holton JL, Lindvall O, Revesz T (2008) Research in motion: the enigma of Parkinson\u2019s disease pathology spread. Nat Rev Neurosci 9(10):741\u2013745. doi:\n                    10.1038\/nrn2477","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"1485_CR26","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/ana.21541","volume":"64","author":"RE Burke","year":"2008","unstructured":"Burke RE, Dauer WT, Vonsattel JP (2008) A critical evaluation of the Braak staging scheme for Parkinson\u2019s disease. Ann Neurol 64(5):485\u2013491. doi:\n                    10.1002\/ana.21541","journal-title":"Ann Neurol"},{"key":"1485_CR27","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.expneurol.2012.01.011","volume":"246","author":"RE Burke","year":"2013","unstructured":"Burke RE, O\u2019Malley K (2013) Axon degeneration in Parkinson\u2019s disease. Exp Neurol 246:72\u201383. doi:\n                    10.1016\/j.expneurol.2012.01.011","journal-title":"Exp Neurol"},{"issue":"7453","key":"1485_CR28","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.1038\/nature12125","volume":"498","author":"J Burre","year":"2013","unstructured":"Burre J, Vivona S, Diao J, Sharma M, Brunger AT, Sudhof TC (2013) Properties of native brain alpha-synuclein. Nature 498(7453):E4\u2013E6. doi:\n                    10.1038\/nature12125","journal-title":"Nature"},{"issue":"1","key":"1485_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cne.901780102","volume":"178","author":"JM Cedarbaum","year":"1978","unstructured":"Cedarbaum JM, Aghajanian GK (1978) Afferent projections to the rat locus coeruleus as determined by a retrograde tracing technique. J Comp Neurol 178(1):1\u201316. doi:\n                    10.1002\/cne.901780102","journal-title":"J Comp Neurol"},{"issue":"3","key":"1485_CR30","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.cell.2005.09.028","volume":"123","author":"S Chandra","year":"2005","unstructured":"Chandra S, Gallardo G, Fern\u00e1ndez-Chac\u00f3n R, Schl\u00fcter OM, S\u00fcdhof TC (2005) Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 123(3):359\u2013361","journal-title":"Cell"},{"issue":"9440","key":"1485_CR31","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","volume":"364","author":"MC Chartier-Harlin","year":"2004","unstructured":"Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, Levecque C, Larvor L, Andrieux J, Hulihan M, Waucquier N, Defebvre L, Amouyel P, Farrer M, Destee A (2004) Alpha-synuclein locus duplication as a cause of familial Parkinson\u2019s disease. Lancet 364(9440):1167\u20131169","journal-title":"Lancet"},{"issue":"6","key":"1485_CR32","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/ana.21995","volume":"67","author":"HC Cheng","year":"2010","unstructured":"Cheng HC, Ulane CM, Burke RE (2010) Clinical progression in Parkinson disease and the neurobiology of axons. Ann Neurol 67(6):715\u2013725. doi:\n                    10.1002\/ana.21995","journal-title":"Ann Neurol"},{"issue":"3","key":"1485_CR33","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.febslet.2004.09.038","volume":"576","author":"W Choi","year":"2004","unstructured":"Choi W, Zibaee S, Jakes R, Serpell LC, Davletov B, Crowther RA, Goedert M (2004) Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein. FEBS Lett 576(3):363\u2013368","journal-title":"FEBS Lett"},{"issue":"1","key":"1485_CR34","doi-asserted-by":"publisher","first-page":"e55375","DOI":"10.1371\/journal.pone.0055375","volume":"8","author":"G Codolo","year":"2013","unstructured":"Codolo G, Plotegher N, Pozzobon T, Brucale M, Tessari I, Bubacco L, de Bernard M (2013) Triggering of inflammasome by aggregated alpha-synuclein, an inflammatory response in synucleinopathies. PLoS One 8(1):e55375. doi:\n                    10.1371\/journal.pone.0055375","journal-title":"PLoS One"},{"issue":"11","key":"1485_CR35","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/3311","volume":"4","author":"KA Conway","year":"1998","unstructured":"Conway KA, Harper JD, Lansbury PT (1998) Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat Med 4(11):1318\u20131320","journal-title":"Nat Med"},{"issue":"10","key":"1485_CR36","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1021\/bi991447r","volume":"39","author":"KA Conway","year":"2000","unstructured":"Conway KA, Harper JD, Lansbury PT (2000) Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson\u2019s disease are typical amyloid. Biochemistry 39(10):2552\u20132563","journal-title":"Biochemistry"},{"issue":"2","key":"1485_CR37","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1073\/pnas.97.2.571","volume":"97","author":"KA Conway","year":"2000","unstructured":"Conway KA, Lee SJ, Rochet JC, Ding TT, Williamson RE, Lansbury PT (2000) Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson\u2019s disease: implications for pathogenesis and therapy. Proc Natl Acad Sci USA 97(2):571\u2013576","journal-title":"Proc Natl Acad Sci USA"},{"key":"1485_CR38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev.biochem.74.082803.133400","volume":"74","author":"MR Cookson","year":"2005","unstructured":"Cookson MR (2005) The biochemistry of Parkinson\u2019s disease. Annu Rev Biochem 74:29\u201352","journal-title":"Annu Rev Biochem"},{"issue":"7","key":"1485_CR39","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1056\/NEJM196902132800701","volume":"280","author":"GC Cotzias","year":"1969","unstructured":"Cotzias GC, Papavasiliou PS, Gellene R (1969) Modification of Parkinsonism\u2014chronic treatment with l-dopa. N Engl J Med 280(7):337\u2013345. doi:\n                    10.1056\/NEJM196902132800701","journal-title":"N Engl J Med"},{"issue":"5","key":"1485_CR40","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.cell.2012.03.037","volume":"149","author":"N Cremades","year":"2012","unstructured":"Cremades N, Cohen SI, Deas E, Abramov AY, Chen AY, Orte A, Sandal M, Clarke RW, Dunne P, Aprile FA, Bertoncini CW, Wood NW, Knowles TP, Dobson CM, Klenerman D (2012) Direct observation of the interconversion of normal and toxic forms of alpha-synuclein. Cell 149(5):1048\u20131059. doi:\n                    10.1016\/j.cell.2012.03.037","journal-title":"Cell"},{"key":"1485_CR41","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1750-1326-7-42","volume":"7","author":"KM Danzer","year":"2012","unstructured":"Danzer KM, Kranich LR, Ruf WP, Cagsal-Getkin O, Winslow AR, Zhu L, Vanderburg CR, McLean PJ (2012) Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol Neurodegener 7:42. doi:\n                    10.1186\/1750-1326-7-42","journal-title":"Mol Neurodegener"},{"issue":"16","key":"1485_CR42","doi-asserted-by":"publisher","first-page":"9443","DOI":"10.1074\/jbc.273.16.9443","volume":"273","author":"WS Davidson","year":"1998","unstructured":"Davidson WS, Jonas A, Clayton DF, George JM (1998) Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem 273(16):9443\u20139449","journal-title":"J Biol Chem"},{"issue":"5","key":"1485_CR43","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/mds.24921","volume":"27","author":"K Del Tredici","year":"2012","unstructured":"Del Tredici K, Braak H (2012) Lewy pathology and neurodegeneration in premotor Parkinson\u2019s disease. Mov Disord 27(5):597\u2013607. doi:\n                    10.1002\/mds.24921","journal-title":"Mov Disord"},{"issue":"7","key":"1485_CR44","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1136\/jnnp-2011-301817","volume":"84","author":"K Del Tredici","year":"2013","unstructured":"Del Tredici K, Braak H (2013) Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson\u2019s disease-related dementia. J Neurol Neurosurg Psychiatry 84(7):774\u2013783. doi:\n                    10.1136\/jnnp-2011-301817","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"1485_CR45","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/jnen\/61.5.413","volume":"61","author":"K Del Tredici","year":"2002","unstructured":"Del Tredici K, R\u00fcb U, De Vos RA, Bohl JR, Braak H (2002) Where does Parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 61(5):413\u2013426","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1\u20132","key":"1485_CR46","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jns.2011.10.003","volume":"314","author":"NJ Diederich","year":"2012","unstructured":"Diederich NJ, Parent A (2012) Parkinson\u2019s disease: acquired frailty of archaic neural networks? J Neurol Sci 314(1\u20132):143\u2013151. doi:\n                    10.1016\/j.jns.2011.10.003","journal-title":"J Neurol Sci"},{"issue":"1","key":"1485_CR47","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00401-014-1284-0","volume":"128","author":"K Doppler","year":"2014","unstructured":"Doppler K, Ebert S, Uceyler N, Trenkwalder C, Ebentheuer J, Volkmann J, Sommer C (2014) Cutaneous neuropathy in Parkinson\u2019s disease: a window into brain pathology. Acta Neuropathol 128(1):99\u2013109. doi:\n                    10.1007\/s00401-014-1284-0","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1485_CR48","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/mds.24003","volume":"27","author":"BN Dugger","year":"2012","unstructured":"Dugger BN, Boeve BF, Murray ME, Parisi JE, Fujishiro H, Dickson DW, Ferman TJ (2012) Rapid eye movement sleep behavior disorder and subtypes in autopsy-confirmed dementia with Lewy bodies. Mov Disord 27(1):72\u201378. doi:\n                    10.1002\/mds.24003","journal-title":"Mov Disord"},{"issue":"2","key":"1485_CR49","doi-asserted-by":"publisher","first-page":"281","DOI":"10.4161\/auto.8.2.18938","volume":"8","author":"D Ebrahimi-Fakhari","year":"2012","unstructured":"Ebrahimi-Fakhari D, McLean PJ, Unni VK (2012) Alpha-synuclein\u2019s degradation in vivo: opening a new (cranial) window on the roles of degradation pathways in Parkinson disease. Autophagy 8(2):281\u2013283. doi:\n                    10.4161\/auto.8.2.18938","journal-title":"Autophagy"},{"issue":"1","key":"1485_CR50","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/2051-5960-1-79","volume":"1","author":"D Ebrahimi-Fakhari","year":"2013","unstructured":"Ebrahimi-Fakhari D, Saidi LJ, Wahlster L (2013) Molecular chaperones and protein folding as therapeutic targets in Parkinson\u2019s disease and other synucleinopathies. Acta Neuropathol Commun 1(1):79. doi:\n                    10.1186\/2051-5960-1-79","journal-title":"Acta Neuropathol Commun"},{"issue":"1\u20132","key":"1485_CR51","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0014-5793(98)01418-5","volume":"440","author":"OM El Agnaf","year":"1998","unstructured":"El Agnaf OM, Jakes R, Curran MD, Middleton D, Ingenito R, Bianchi E, Pessi A, Neill D, Wallace A (1998) Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments. FEBS Lett 440(1\u20132):71\u201375","journal-title":"FEBS Lett"},{"issue":"4","key":"1485_CR52","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1006\/jmbi.2001.4538","volume":"307","author":"D Eliezer","year":"2001","unstructured":"Eliezer D, Kutluay E, Bussell R Jr, Browne G (2001) Conformational properties of alpha-synuclein in its free and lipid-associated states. J Mol Biol 307(4):1061\u20131073","journal-title":"J Mol Biol"},{"issue":"20","key":"1485_CR53","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","volume":"30","author":"E Emmanouilidou","year":"2010","unstructured":"Emmanouilidou E, Melachroinou K, Roumeliotis T, Garbis SD, Ntzouni M, Margaritis LH, Stefanis L, Vekrellis K (2010) Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci 30(20):6838\u20136851","journal-title":"J Neurosci"},{"issue":"40","key":"1485_CR54","doi-asserted-by":"publisher","first-page":"35104","DOI":"10.1074\/jbc.M111.247965","volume":"286","author":"KL Emmer","year":"2011","unstructured":"Emmer KL, Waxman EA, Covy JP, Giasson BI (2011) E46K human alpha-synuclein transgenic mice develop Lewy-like and tau pathology associated with age-dependent, detrimental motor impairment. J Biol Chem 286(40):35104\u201335118","journal-title":"J Biol Chem"},{"issue":"17","key":"1485_CR55","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1093\/hmg\/ddu165","volume":"23","author":"MB Fares","year":"2014","unstructured":"Fares MB, Ait-Bouziad N, Dikiy I, Mbefo MK, Jovicic A, Kiely A, Holton JL, Lee SJ, Gitler AD, Eliezer D, Lashuel HA (2014) The novel Parkinson\u2019s disease linked mutation G51D attenuates in vitro aggregation and membrane binding of alpha-synuclein, and enhances its secretion and nuclear localization in cells. Hum Mol Genet 23(17):4491\u20134509. doi:\n                    10.1093\/hmg\/ddu165","journal-title":"Hum Mol Genet"},{"issue":"2","key":"1485_CR56","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/ana.10846","volume":"55","author":"M Farrer","year":"2004","unstructured":"Farrer M, Kachergus J, Forno L, Lincoln S, Wang DS, Hulihan M, Maraganore D, Gwinn-Hardy K, Wszolek Z, Dickson D, Langston JW (2004) Comparison of kindreds with Parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol 55(2):174\u2013179","journal-title":"Ann Neurol"},{"key":"1485_CR57","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/B978-0-12-374028-1.00018-X","volume-title":"Parkinson\u2019s disease: molecular and therapeutic insights from model systems","author":"DL Fortin","year":"2008","unstructured":"Fortin DL, Nemani VM, Edwards RH (2008) A-synuclein, CSPa, SNAREs and neuroprotection in vivo. In: Naas R, Przedborski S (eds) Parkinson\u2019s disease: molecular and therapeutic insights from model systems, 1st edn. Academic Press, Waltham, pp 237\u2013246","edition":"1"},{"issue":"4","key":"1485_CR58","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ana.23747","volume":"72","author":"EC Freundt","year":"2012","unstructured":"Freundt EC, Maynard N, Clancy EK, Roy S, Bousset L, Sourigues Y, Covert M, Melki R, Kirkegaard K, Brahic M (2012) Neuron-to-neuron transmission of alpha-synuclein fibrils through axonal transport. Ann Neurol 72(4):517\u2013524. doi:\n                    10.1002\/ana.23747","journal-title":"Ann Neurol"},{"key":"1485_CR59","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb841","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, Iwatsubo T (2002) A-synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4:160\u2013164","journal-title":"Nat Cell Biol"},{"issue":"2","key":"1485_CR60","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/0896-6273(95)90040-3","volume":"15","author":"JM George","year":"1995","unstructured":"George JM, Jin H, Woods WS, Clayton DF (1995) Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 15(2):361\u2013372","journal-title":"Neuron"},{"issue":"40","key":"1485_CR61","doi-asserted-by":"publisher","first-page":"6925","DOI":"10.1021\/bi400999d","volume":"52","author":"D Ghosh","year":"2013","unstructured":"Ghosh D, Mondal M, Mohite GM, Singh PK, Ranjan P, Anoop A, Ghosh S, Jha NN, Kumar A, Maji SK (2013) The Parkinson\u2019s disease-associated H50Q mutation accelerates alpha-synuclein aggregation in vitro. Biochemistry 52(40):6925\u20136927. doi:\n                    10.1021\/bi400999d","journal-title":"Biochemistry"},{"issue":"41","key":"1485_CR62","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.1021\/bi5010365","volume":"53","author":"D Ghosh","year":"2014","unstructured":"Ghosh D, Sahay S, Ranjan P, Salot S, Mohite GM, Singh PK, Dwivedi S, Carvalho E, Banerjee R, Kumar A, Maji SK (2014) The newly discovered Parkinson\u2019s disease associated Finnish mutation (A53E) attenuates alpha-synuclein aggregation and membrane binding. Biochemistry 53(41):6419\u20136421. doi:\n                    10.1021\/bi5010365","journal-title":"Biochemistry"},{"key":"1485_CR63","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1006\/exnr.2001.7805","volume":"172","author":"BI Giasson","year":"2001","unstructured":"Giasson BI, Duda JE, Forman MS, Lee VM-Y, Trojanoswki JQ (2001) Prominent perikaryal expression of \u03b1- and \u03b2-synuclein in neurons of dorsal root ganglion and in medullary neurons. Exp Neurol 172:354\u2013362","journal-title":"Exp Neurol"},{"issue":"4","key":"1485_CR64","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","volume":"34","author":"BI Giasson","year":"2002","unstructured":"Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM (2002) Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron 34(4):521\u2013533","journal-title":"Neuron"},{"key":"1485_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0092-8674(03)00509-9","volume":"114","author":"BI Giasson","year":"2003","unstructured":"Giasson BI, Lee VM-Y (2003) Are ubiquitination pathways central to Parkinson\u2019s disease? Cell 114:1\u20138","journal-title":"Cell"},{"key":"1485_CR66","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1074\/jbc.M008919200","volume":"276","author":"BI Giasson","year":"2001","unstructured":"Giasson BI, Murray IV, Trojanowski JQ, Lee VM-Y (2001) A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly. J Biol Chem 276:2380\u20132386","journal-title":"J Biol Chem"},{"issue":"12","key":"1485_CR67","doi-asserted-by":"publisher","first-page":"7619","DOI":"10.1074\/jbc.274.12.7619","volume":"274","author":"BI Giasson","year":"1999","unstructured":"Giasson BI, Uryu K, Trojanowski JQ, Lee VM-Y (1999) Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro. J Biol Chem 274(12):7619\u20137622","journal-title":"J Biol Chem"},{"key":"1485_CR68","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/35081564","volume":"2","author":"M Goedert","year":"2001","unstructured":"Goedert M (2001) Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci 2:492\u2013501","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"1485_CR69","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","volume":"9","author":"M Goedert","year":"2013","unstructured":"Goedert M, Spillantini MG, Del Tredici K, Braak H (2013) 100\u00a0years of Lewy pathology. Nat Rev Neurol 9(1):13\u201324. doi:\n                    10.1038\/nrneurol.2012.242","journal-title":"Nat Rev Neurol"},{"key":"1485_CR70","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1172\/JCI66029","volume":"123","author":"TE Golde","year":"2013","unstructured":"Golde TE, Borchelt DR, Giasson BI, Lewis J (2013) Thinking laterally about neurodegenerative proteinopathies. J Clin Invest 123:1847\u20131855","journal-title":"J Clin Invest"},{"issue":"4615","key":"1485_CR71","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1126\/science.6308771","volume":"221","author":"JE Goldman","year":"1983","unstructured":"Goldman JE, Yen SH, Chiu FC, Peress NS (1983) Lewy bodies of Parkinson\u2019s disease contain neurofilament antigens. Science 221(4615):1082\u20131084","journal-title":"Science"},{"issue":"9","key":"1485_CR72","doi-asserted-by":"publisher","first-page":"7800","DOI":"10.1074\/jbc.M411638200","volume":"280","author":"EA Greenbaum","year":"2005","unstructured":"Greenbaum EA, Graves CL, Mishizen-Eberz AJ, Lupoli MA, Lynch DR, Englander SW, Axelsen PH, Giasson BI (2005) The E46K mutation in alpha -synuclein increases amyloid fibril formation. J Biol Chem 280(9):7800\u20137807","journal-title":"J Biol Chem"},{"issue":"4","key":"1485_CR73","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1136\/jnnp.16.4.213","volume":"16","author":"JG Greenfield","year":"1953","unstructured":"Greenfield JG, Bosanquet FD (1953) The brain-stem lesions in parkinsonism. J Neurol Neurosurg Psychiatry 16(4):213\u2013226","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"1485_CR74","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.neurobiolaging.2008.03.015","volume":"31","author":"S Greffard","year":"2010","unstructured":"Greffard S, Verny M, Bonnet AM, Seilhean D, Hauw JJ, Duyckaerts C (2010) A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death. Neurobiol Aging 31(1):99\u2013103. doi:\n                    10.1016\/j.neurobiolaging.2008.03.015","journal-title":"Neurobiol Aging"},{"issue":"1","key":"1485_CR75","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cell.2013.05.057","volume":"154","author":"JL Guo","year":"2013","unstructured":"Guo JL, Covell DJ, Daniels JP, Iba M, Stieber A, Zhang B, Riddle DM, Kwong LK, Xu Y, Trojanowski JQ, Lee VM (2013) Distinct alpha-synuclein strains differentially promote tau inclusions in neurons. Cell 154(1):103\u2013117. doi:\n                    10.1016\/j.cell.2013.05.057","journal-title":"Cell"},{"key":"1485_CR76","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev-neuro-071013-014317","volume":"37","author":"NA Haelterman","year":"2014","unstructured":"Haelterman NA, Yoon WH, Sandoval H, Jaiswal M, Shulman JM, Bellen HJ (2014) A mitocentric view of Parkinson\u2019s disease. Annu Rev Neurosci 37:137\u2013159. doi:\n                    10.1146\/annurev-neuro-071013-014317","journal-title":"Annu Rev Neurosci"},{"issue":"2","key":"1485_CR77","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s004010050693","volume":"94","author":"K Hague","year":"1997","unstructured":"Hague K, Lento P, Morgello S, Caro S, Kaufmann H (1997) The distribution of Lewy bodies in pure autonomic failure: autopsy findings and review of the literature. Acta Neuropathol 94(2):192\u2013196","journal-title":"Acta Neuropathol"},{"issue":"4","key":"1485_CR78","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-008-0344-8","volume":"115","author":"G Halliday","year":"2008","unstructured":"Halliday G, Hely M, Reid W, Morris J (2008) The progression of pathology in longitudinally followed patients with Parkinson\u2019s disease. Acta Neuropathol 115(4):409\u2013415. doi:\n                    10.1007\/s00401-008-0344-8","journal-title":"Acta Neuropathol"},{"issue":"2","key":"1485_CR79","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0006-8993(98)00514-9","volume":"799","author":"M Hashimoto","year":"1998","unstructured":"Hashimoto M, Hsu LJ, Sisk A, Xia Y, Takeda A, Sundsmo M, Masliah E (1998) Human recombinant NACP\/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease. Brain Res 799(2):301\u2013306","journal-title":"Brain Res"},{"key":"1485_CR80","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.nbd.2012.10.011","volume":"51","author":"DN Hauser","year":"2013","unstructured":"Hauser DN, Hastings TG (2013) Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease and monogenic parkinsonism. Neurobiol Dis 51:35\u201342. doi:\n                    10.1016\/j.nbd.2012.10.011","journal-title":"Neurobiol Dis"},{"issue":"6","key":"1485_CR81","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","volume":"33","author":"CH Hawkes","year":"2007","unstructured":"Hawkes CH, Del Tredici K, Braak H (2007) Parkinson\u2019s disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol 33(6):599\u2013614. doi:\n                    10.1111\/j.1365-2990.2007.00874.x","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"3","key":"1485_CR82","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/1531-8249(200003)47:3<345::AID-ANA10>3.0.CO;2-V","volume":"47","author":"JM Henderson","year":"2000","unstructured":"Henderson JM, Carpenter K, Cartwright H, Halliday GM (2000) Degeneration of the centre median-parafascicular complex in Parkinson\u2019s disease. Ann Neurol 47(3):345\u2013352","journal-title":"Ann Neurol"},{"issue":"2","key":"1485_CR83","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00401-013-1214-6","volume":"127","author":"D Hilton","year":"2014","unstructured":"Hilton D, Stephens M, Kirk L, Edwards P, Potter R, Zajicek J, Broughton E, Hagan H, Carroll C (2014) Accumulation of alpha-synuclein in the bowel of patients in the pre-clinical phase of Parkinson\u2019s disease. Acta Neuropathol 127(2):235\u2013241. doi:\n                    10.1007\/s00401-013-1214-6","journal-title":"Acta Neuropathol"},{"key":"1485_CR84","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-015-1451-y","author":"GU H\u00f6glinger","year":"2015","unstructured":"H\u00f6glinger GU, Alvarez-Fischer D, Arias-Carri\u00f3n O, Djufri M, Windolph A, Keber U, Borta A, Ries V, Schwarting RK, Scheller D, Oertel WH (2015) A new dopaminergic nigro-olfactory projection. Acta Neuropathol. doi:\n                    10.1007\/s00401-015-1451-y","journal-title":"Acta Neuropathol"},{"issue":"2 Suppl 2","key":"1485_CR85","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1212\/WNL.51.2_Suppl_2.S2","volume":"51","author":"O Hornykiewicz","year":"1998","unstructured":"Hornykiewicz O (1998) Biochemical aspects of Parkinson\u2019s disease. Neurology 51(2 Suppl 2):S2\u2013S9","journal-title":"Neurology"},{"issue":"4","key":"1485_CR86","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/bpa.12182","volume":"25","author":"DR Howlett","year":"2015","unstructured":"Howlett DR, Whitfield D, Johnson M, Attems J, O\u2019Brien JT, Aarsland D, Lai MK, Lee JH, Chen C, Ballard C, Hortobagyi T, Francis PT (2015) Regional multiple pathology scores are associated with cognitive decline in Lewy body dementias. Brain Pathol 25(4):401\u2013408. doi:\n                    10.1111\/bpa.12182","journal-title":"Brain Pathol"},{"issue":"8","key":"1485_CR87","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1097\/00005072-199608000-00004","volume":"55","author":"MC Irizarry","year":"1996","unstructured":"Irizarry MC, Kim TW, McNamara M, Tanzi RE, George JM, Clayton DF, Hyman BT (1996) Characterization of the precursor protein of the non-A beta component of senile plaques (NACP) in the human central nervous system. J Neuropathol Exp Neurol 55(8):889\u2013895","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"1485_CR88","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","volume":"14","author":"A Iwai","year":"1995","unstructured":"Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L, de Silva HA, Kittel A, Saitoh T (1995) The precursor protein of non-A beta component of Alzheimer\u2019s disease amyloid is a presynaptic protein of the central nervous system. Neuron 14(2):467\u2013475","journal-title":"Neuron"},{"issue":"1","key":"1485_CR89","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0014-5793(94)00395-5","volume":"345","author":"R Jakes","year":"1994","unstructured":"Jakes R, Spillantini MG, Goedert M (1994) Identification of two distinct synucleins from human brain. FEBS Lett 345(1):27\u201332","journal-title":"FEBS Lett"},{"issue":"1","key":"1485_CR90","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/mds.23795","volume":"27","author":"KA Jellinger","year":"2012","unstructured":"Jellinger KA (2012) Neuropathology of sporadic Parkinson\u2019s disease: evaluation and changes of concepts. Mov Disord 27(1):8\u201330. doi:\n                    10.1002\/mds.23795","journal-title":"Mov Disord"},{"issue":"1","key":"1485_CR91","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00401-008-0381-3","volume":"116","author":"ME Kalaitzakis","year":"2008","unstructured":"Kalaitzakis ME, Graeber MB, Gentleman SM, Pearce RK (2008) Controversies over the staging of alpha-synuclein pathology in Parkinson\u2019s disease. Acta Neuropathol 116(1):125\u2013128. doi:\n                    10.1007\/s00401-008-0381-3","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1485_CR92","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1750-3639.2011.00509.x","volume":"22","author":"T Kanazawa","year":"2012","unstructured":"Kanazawa T, Adachi E, Orimo S, Nakamura A, Mizusawa H, Uchihara T (2012) Pale neurites, premature alpha-synuclein aggregates with centripetal extension from axon collaterals. Brain Pathol 22(1):67\u201378. doi:\n                    10.1111\/j.1750-3639.2011.00509.x","journal-title":"Brain Pathol"},{"issue":"3","key":"1485_CR93","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1750-3639.2008.00140.x","volume":"18","author":"T Kanazawa","year":"2008","unstructured":"Kanazawa T, Uchihara T, Takahashi A, Nakamura A, Orimo S, Mizusawa H (2008) Three-layered structure shared between Lewy bodies and Lewy neurites\u2014three-dimensional reconstruction of triple-labeled sections. Brain Pathol 18(3):415\u2013422. doi:\n                    10.1111\/j.1750-3639.2008.00140.x","journal-title":"Brain Pathol"},{"issue":"5618","key":"1485_CR94","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1126\/science.1079469","volume":"300","author":"R Kayed","year":"2003","unstructured":"Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300(5618):486\u2013489","journal-title":"Science"},{"issue":"32","key":"1485_CR95","doi-asserted-by":"publisher","first-page":"21856","DOI":"10.1074\/jbc.M114.553297","volume":"289","author":"O Khalaf","year":"2014","unstructured":"Khalaf O, Fauvet B, Oueslati A, Dikiy I, Mahul-Mellier AL, Ruggeri FS, Mbefo MK, Vercruysse F, Dietler G, Lee SJ, Eliezer D, Lashuel HA (2014) The H50Q mutation enhances alpha-synuclein aggregation, secretion, and toxicity. J Biol Chem 289(32):21856\u201321876. doi:\n                    10.1074\/jbc.M114.553297","journal-title":"J Biol Chem"},{"issue":"5","key":"1485_CR96","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00401-013-1096-7","volume":"125","author":"AP Kiely","year":"2013","unstructured":"Kiely AP, Asi YT, Kara E, Limousin P, Ling H, Lewis P, Proukakis C, Quinn N, Lees AJ, Hardy J, Revesz T, Houlden H, Holton JL (2013) Alpha-synucleinopathy associated with G51D SNCA mutation: a link between Parkinson\u2019s disease and multiple system atrophy? Acta Neuropathol 125(5):753\u2013769. doi:\n                    10.1007\/s00401-013-1096-7","journal-title":"Acta Neuropathol"},{"key":"1485_CR97","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1038\/ncomms2534","volume":"4","author":"C Kim","year":"2013","unstructured":"Kim C, Ho DH, Suk JE, You S, Michael S, Kang J, Joong LS, Masliah E, Hwang D, Lee HJ, Lee SJ (2013) Neuron-released oligomeric alpha-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia. Nat Commun 4:1562. doi:\n                    10.1038\/ncomms2534","journal-title":"Nat Commun"},{"issue":"2","key":"1485_CR98","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jmb.2006.05.004","volume":"360","author":"YS Kim","year":"2006","unstructured":"Kim YS, Laurine E, Woods W, Lee SJ (2006) A novel mechanism of interaction between alpha-synuclein and biological membranes. J Mol Biol 360(2):386\u2013397. doi:\n                    10.1016\/j.jmb.2006.05.004","journal-title":"J Mol Biol"},{"issue":"5","key":"1485_CR99","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1073\/pnas.0536383100","volume":"100","author":"D Kirik","year":"2003","unstructured":"Kirik D, Annett LE, Burger C, Muzyczka N, Mandel RJ, Bjorklund A (2003) Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson\u2019s disease. Proc Natl Acad Sci USA 100(5):2884\u20132889. doi:\n                    10.1073\/pnas.0536383100","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"1485_CR100","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1523\/JNEUROSCI.22-07-02780.2002","volume":"22","author":"D Kirik","year":"2002","unstructured":"Kirik D, Rosenblad C, Burger C, Lundberg C, Johansen TE, Muzyczka N, Mandel RJ, Bjorklund A (2002) Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system. J Neurosci 22(7):2780\u20132791","journal-title":"J Neurosci"},{"issue":"5","key":"1485_CR101","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1089\/10430340252837206","volume":"13","author":"RL Klein","year":"2002","unstructured":"Klein RL, King MA, Hamby ME, Meyer EM (2002) Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia nigra. Hum Gene Ther 13(5):605\u2013612. doi:\n                    10.1089\/10430340252837206","journal-title":"Hum Gene Ther"},{"issue":"2","key":"1485_CR102","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/BF00690978","volume":"42","author":"K Kosaka","year":"1978","unstructured":"Kosaka K (1978) Lewy bodies in cerebral cortex, report of three cases. Acta Neuropathol 42(2):127\u2013134","journal-title":"Acta Neuropathol"},{"key":"1485_CR103","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1440-1789.1996.tb00152.x","volume":"16","author":"K Kosaka","year":"1996","unstructured":"Kosaka K, Iseki E, Odawara T, Yamamoto T (1996) Cerebral type of Lewy body disease. Neuropathology 16:32\u201335","journal-title":"Neuropathology"},{"issue":"4","key":"1485_CR104","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1159\/000161560","volume":"26","author":"GG Kovacs","year":"2008","unstructured":"Kovacs GG, Alafuzoff I, Al-Sarraj S, Arzberger T, Bogdanovic N, Capellari S, Ferrer I, Gelpi E, Kovari V, Kretzschmar H, Nagy Z, Parchi P, Seilhean D, Soininen H, Troakes C, Budka H (2008) Mixed brain pathologies in dementia: the BrainNet Europe consortium experience. Dement Geriatr Cogn Disord 26(4):343\u2013350. doi:\n                    10.1159\/000161560","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"1485_CR105","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00401-012-0964-x","volume":"124","author":"GG Kovacs","year":"2012","unstructured":"Kovacs GG, Wagner U, Dumont B, Pikkarainen M, Osman AA, Streichenberger N, Leisser I, Verchere J, Baron T, Alafuzoff I, Budka H, Perret-Liaudet A, Lachmann I (2012) An antibody with high reactivity for disease-associated alpha-synuclein reveals extensive brain pathology. Acta Neuropathol 124(1):37\u201350. doi:\n                    10.1007\/s00401-012-0964-x","journal-title":"Acta Neuropathol"},{"issue":"6","key":"1485_CR106","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1523\/JNEUROSCI.4564-06.2007","volume":"27","author":"ML Kramer","year":"2007","unstructured":"Kramer ML, Schulz-Schaeffer WJ (2007) Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J Neurosci 27(6):1405\u20131410. doi:\n                    10.1523\/JNEUROSCI.4564-06.2007","journal-title":"J Neurosci"},{"issue":"2","key":"1485_CR107","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kr\u00fcger","year":"1998","unstructured":"Kr\u00fcger R, Kuhn W, M\u00fcller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Sch\u00f6ls L, Riess O (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease. Nat Genet 18(2):106\u2013108","journal-title":"Nat Genet"},{"issue":"8","key":"1485_CR108","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1523\/JNEUROSCI.3809-03.2004","volume":"24","author":"HJ Lee","year":"2004","unstructured":"Lee HJ, Khoshaghideh F, Patel S, Lee SJ (2004) Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway. J Neurosci 24(8):1888\u20131896. doi:\n                    10.1523\/JNEUROSCI.3809-03.2004","journal-title":"J Neurosci"},{"issue":"25","key":"1485_CR109","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.1523\/JNEUROSCI.0692-05.2005","volume":"25","author":"HJ Lee","year":"2005","unstructured":"Lee HJ, Patel S, Lee SJ (2005) Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J Neurosci 25(25):6016\u20136024","journal-title":"J Neurosci"},{"issue":"9","key":"1485_CR110","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.biocel.2008.01.017","volume":"40","author":"HJ Lee","year":"2008","unstructured":"Lee HJ, Suk JE, Bae EJ, Lee JH, Paik SR, Lee SJ (2008) Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein. Int J Biochem Cell Biol 40(9):1835\u20131849","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"1485_CR111","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.bbrc.2008.05.045","volume":"372","author":"HJ Lee","year":"2008","unstructured":"Lee HJ, Suk JE, Bae EJ, Lee SJ (2008) Clearance and deposition of extracellular alpha-synuclein aggregates in microglia. Biochem Biophys Res Commun 372(3):423\u2013428. doi:\n                    10.1016\/j.bbrc.2008.05.045","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"1485_CR112","doi-asserted-by":"publisher","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","volume":"285","author":"HJ Lee","year":"2010","unstructured":"Lee HJ, Suk JE, Patrick C, Bae EJ, Cho JH, Rho S, Hwang D, Masliah E, Lee SJ (2010) Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J Biol Chem 285(12):9262\u20139272","journal-title":"J Biol Chem"},{"issue":"7 Suppl","key":"1485_CR113","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1212\/WNL.0b013e318198daec","volume":"72","author":"AJ Lees","year":"2009","unstructured":"Lees AJ (2009) The Parkinson chimera. Neurology 72(7 Suppl):S2\u2013S11. doi:\n                    10.1212\/WNL.0b013e318198daec","journal-title":"Neurology"},{"issue":"6","key":"1485_CR114","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/mds.21855","volume":"23","author":"AJ Lees","year":"2008","unstructured":"Lees AJ, Selikhova M, Andrade LA, Duyckaerts C (2008) The black stuff and Konstantin Nikolaevich Tretiakoff. Mov Disord 23(6):777\u2013783. doi:\n                    10.1002\/mds.21855","journal-title":"Mov Disord"},{"issue":"2","key":"1485_CR115","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s12035-012-8267-8","volume":"47","author":"CM Lema Tom\u00e9","year":"2013","unstructured":"Lema Tom\u00e9 CM, Tyson T, Rey NL, Grathwohl S, Britschgi M, Brundin P (2013) Inflammation and alpha-synuclein\u2019s prion-like behavior in Parkinson\u2019s disease\u2014is there a link? Mol Neurobiol 47(2):561\u2013574. doi:\n                    10.1007\/s12035-012-8267-8","journal-title":"Mol Neurobiol"},{"issue":"4","key":"1485_CR116","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/ana.23894","volume":"73","author":"S Lesage","year":"2013","unstructured":"Lesage S, Anheim M, Letournel F, Bousset L, Honore A, Rozas N, Pieri L, Madiona K, D\u00fcrr A, Melki R, Verny C, Brice A (2013) G51D alpha-synuclein mutation causes a novel Parkinsonian-pyramidal syndrome. Ann Neurol 73(4):459\u2013471. doi:\n                    10.1002\/ana.23894","journal-title":"Ann Neurol"},{"issue":"22","key":"1485_CR117","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1093\/hmg\/10.22.2525","volume":"10","author":"C Lesuisse","year":"2001","unstructured":"Lesuisse C, Xu G, Anderson J, Wong M, Jankowsky J, Holtz G, Gonzalez V, Wong PC, Price DL, Tang F, Wagner S, Borchelt DR (2001) Hyper-expression of human apolipoprotein E4 in astroglia and neurons does not enhance amyloid deposition in transgenic mice. Hum Mol Genet 10(22):2525\u20132537","journal-title":"Hum Mol Genet"},{"issue":"38","key":"1485_CR118","doi-asserted-by":"publisher","first-page":"11604","DOI":"10.1021\/bi010616g","volume":"40","author":"J Li","year":"2001","unstructured":"Li J, Uversky VN, Fink AL (2001) Effect of familial Parkinson\u2019s disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein. Biochemistry 40(38):11604\u201311613","journal-title":"Biochemistry"},{"issue":"1","key":"1485_CR119","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00441-012-1362-3","volume":"349","author":"P Lingor","year":"2012","unstructured":"Lingor P, Koch JC, Tonges L, Bahr M (2012) Axonal degeneration as a therapeutic target in the CNS. Cell Tissue Res 349(1):289\u2013311. doi:\n                    10.1007\/s00441-012-1362-3","journal-title":"Cell Tissue Res"},{"issue":"24","key":"1485_CR120","doi-asserted-by":"publisher","first-page":"22670","DOI":"10.1074\/jbc.M501508200","volume":"280","author":"CW Liu","year":"2005","unstructured":"Liu CW, Giasson BI, Lewis KA, Lee VM, Demartino GN, Thomas PJ (2005) A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease. J Biol Chem 280(24):22670\u201322678. doi:\n                    10.1074\/jbc.M501508200","journal-title":"J Biol Chem"},{"issue":"5","key":"1485_CR121","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1523\/JNEUROSCI.6202-08.2009","volume":"29","author":"J Liu","year":"2009","unstructured":"Liu J, Zhang JP, Shi M, Quinn T, Bradner J, Beyer R, Chen S, Zhang J (2009) Rab11a and hsp90 regulate recycling of extracellular alpha-synuclein. J Neurosci 29(5):1480\u20131485","journal-title":"J Neurosci"},{"issue":"16","key":"1485_CR122","doi-asserted-by":"publisher","first-page":"10813","DOI":"10.1073\/pnas.152339799","volume":"99","author":"C Lo Bianco","year":"2002","unstructured":"Lo Bianco C, Ridet JL, Schneider BL, Deglon N, Aebischer P (2002) Alpha-synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson\u2019s disease. Proc Natl Acad Sci USA 99(16):10813\u201310818. doi:\n                    10.1073\/pnas.152339799","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"1485_CR123","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1001\/archneur.62.6.1004","volume":"62","author":"ED Louis","year":"2005","unstructured":"Louis ED, Honig LS, Vonsattel JP, Maraganore DM, Borden S, Moskowitz CB (2005) Essential tremor associated with focal nonnigral Lewy bodies: a clinicopathologic study. Arch Neurol 62(6):1004\u20131007. doi:\n                    10.1001\/archneur.62.6.1004","journal-title":"Arch Neurol"},{"issue":"6109","key":"1485_CR124","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm V, Carroll J, Zhang B, O\u2019Brien P, Trojanowski JQ, Lee VM (2012) Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338(6109):949\u2013953. doi:\n                    10.1126\/science.1227157","journal-title":"Science"},{"issue":"5","key":"1485_CR125","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1084\/jem.20112457","volume":"209","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm VM, Zhang B, O\u2019Brien P, Trojanowski JQ, Lee VM (2012) Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. J Exp Med 209(5):975\u2013986. doi:\n                    10.1084\/jem.20112457","journal-title":"J Exp Med"},{"issue":"47","key":"1485_CR126","doi-asserted-by":"publisher","first-page":"20051","DOI":"10.1073\/pnas.0908005106","volume":"106","author":"KC Luk","year":"2009","unstructured":"Luk KC, Song C, O\u2019Brien P, Stieber A, Branch JR, Brunden KR, Trojanowski JQ, Lee VM (2009) Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci USA 106(47):20051\u201320056","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"1485_CR127","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1096\/fj.12-223842","volume":"27","author":"C Manzoni","year":"2013","unstructured":"Manzoni C, Lewis PA (2013) Dysfunction of the autophagy\/lysosomal degradation pathway is a shared feature of the genetic synucleinopathies. FASEB J 27(9):3424\u20133429. doi:\n                    10.1096\/fj.12-223842","journal-title":"FASEB J"},{"key":"1485_CR128","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-genom-082410-101440","volume":"12","author":"I Martin","year":"2011","unstructured":"Martin I, Dawson VL, Dawson TM (2011) Recent advances in the genetics of Parkinson\u2019s disease. Annu Rev Genomics Hum Genet 12:301\u2013325. doi:\n                    10.1146\/annurev-genom-082410-101440","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"1485_CR129","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s40478-014-0088-8","volume":"2","author":"M Masuda-Suzukake","year":"2014","unstructured":"Masuda-Suzukake M, Nonaka T, Hosokawa M, Kubo M, Shimozawa A, Akiyama H, Hasegawa M (2014) Pathological alpha-synuclein propagates through neural networks. Acta Neuropathol Commun 2:88. doi:\n                    10.1186\/s40478-014-0088-8","journal-title":"Acta Neuropathol Commun"},{"issue":"Pt 4","key":"1485_CR130","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/brain\/awt037","volume":"136","author":"M Masuda-Suzukake","year":"2013","unstructured":"Masuda-Suzukake M, Nonaka T, Hosokawa M, Oikawa T, Arai T, Akiyama H, Mann DM, Hasegawa M (2013) Prion-like spreading of pathological alpha-synuclein in brain. Brain 136(Pt 4):1128\u20131138. doi:\n                    10.1093\/brain\/awt037","journal-title":"Brain"},{"issue":"2","key":"1485_CR131","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1523\/JNEUROSCI.4029-08.2009","volume":"29","author":"W Matsuda","year":"2009","unstructured":"Matsuda W, Furuta T, Nakamura KC, Hioki H, Fujiyama F, Arai R, Kaneko T (2009) Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum. J Neurosci 29(2):444\u2013453. doi:\n                    10.1523\/JNEUROSCI.4029-08.2009","journal-title":"J Neurosci"},{"key":"1485_CR132","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1016\/S1353-8020(13)70017-8","volume":"20","author":"H McCann","year":"2014","unstructured":"McCann H, Stevens CH, Cartwright H, Halliday GM (2014) \u0391-synucleinopathy phenotypes. Parkinsonism Relat Disord 20:S62\u2013S67. doi:\n                    10.1016\/s1353-8020(13)70017-8","journal-title":"Parkinsonism Relat Disord"},{"issue":"15","key":"1485_CR133","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1002\/mds.22775","volume":"24","author":"Y Miki","year":"2009","unstructured":"Miki Y, Mori F, Wakabayashi K, Kuroda N, Orimo S (2009) Incidental Lewy body disease restricted to the heart and stellate ganglia. Mov Disord 24(15):2299\u20132301. doi:\n                    10.1002\/mds.22775","journal-title":"Mov Disord"},{"issue":"12","key":"1485_CR134","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1007\/s00702-005-0378-1","volume":"112","author":"DW Miller","year":"2005","unstructured":"Miller DW, Johnson JM, Solano SM, Hollingsworth ZR, Standaert DG, Young AB (2005) Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia. J Neural Transm 112(12):1613\u20131624. doi:\n                    10.1007\/s00702-005-0378-1","journal-title":"J Neural Transm"},{"issue":"23","key":"1485_CR135","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1212\/01.wnl.0000264429.59379.d9","volume":"68","author":"A Minguez-Castellanos","year":"2007","unstructured":"Minguez-Castellanos A, Chamorro CE, Escamilla-Sevilla F, Ortega-Moreno A, Rebollo AC, Gomez-Rio M, Concha A, Munoz DG (2007) Do alpha-synuclein aggregates in autonomic plexuses predate Lewy body disorders?: a cohort study. Neurology 68(23):2012\u20132018. doi:\n                    10.1212\/01.wnl.0000264429.59379.d9","journal-title":"Neurology"},{"key":"1485_CR136","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0072-9752(07)83009-0","volume":"83","author":"Y Mizuno","year":"2007","unstructured":"Mizuno Y, Hattori N, Mochizuki H (2007) Genetic aspects of Parkinson\u2019s disease. Handb Clin Neurol 83:217\u2013244. doi:\n                    10.1016\/s0072-9752(07)83009-0","journal-title":"Handb Clin Neurol"},{"issue":"9","key":"1485_CR137","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1016\/j.neurobiolaging.2011.06.022","volume":"33","author":"AL Mougenot","year":"2012","unstructured":"Mougenot AL, Nicot S, Bencsik A, Morignat E, Verchere J, Lakhdar L, Legastelois S, Baron T (2012) Prion-like acceleration of a synucleinopathy in a transgenic mouse model. Neurobiol Aging 33(9):2225\u20132228. doi:\n                    10.1016\/j.neurobiolaging.2011.06.022","journal-title":"Neurobiol Aging"},{"issue":"14","key":"1485_CR138","doi-asserted-by":"publisher","first-page":"9843","DOI":"10.1074\/jbc.274.14.9843","volume":"274","author":"L Narhi","year":"1999","unstructured":"Narhi L, Wood SJ, Steavenson S, Jiang Y, Wu GM, Anafi D, Kaufman SA, Martin F, Sitney K, Denis P, Louis JC, Wypych J, Biere AL, Citron M (1999) Both familial Parkinson\u2019s disease mutations accelerate alpha-synuclein aggregation. J Biol Chem 274(14):9843\u20139846","journal-title":"J Biol Chem"},{"key":"1485_CR139","volume-title":"The human brain in photographs and diagrams","author":"J Nolte","year":"2007","unstructured":"Nolte J, Angevine JB (2007) The human brain in photographs and diagrams, 3rd edn. Mosby\/Elsevier, Philadelphia","edition":"3"},{"issue":"45","key":"1485_CR140","doi-asserted-by":"publisher","first-page":"34885","DOI":"10.1074\/jbc.M110.148460","volume":"285","author":"T Nonaka","year":"2010","unstructured":"Nonaka T, Watanabe ST, Iwatsubo T, Hasegawa M (2010) Seeded aggregation and toxicity of alpha-synuclein and tau: cellular models of neurodegenerative diseases. J Biol Chem 285(45):34885\u201334898. doi:\n                    10.1074\/jbc.M110.148460","journal-title":"J Biol Chem"},{"key":"1485_CR141","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/00005072-196104000-00007","volume":"20","author":"H Okazaki","year":"1961","unstructured":"Okazaki H, Lipkin LE, Aronson SM (1961) Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion. J Neuropathol Exp Neurol 20:237\u2013244","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"1485_CR142","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.parkreldis.2012.01.009","volume":"18","author":"S Orimo","year":"2012","unstructured":"Orimo S, Suzuki M, Inaba A, Mizusawa H (2012) 123I-MIBG myocardial scintigraphy for differentiating Parkinson\u2019s disease from other neurodegenerative Parkinsonism: a systematic review and meta-analysis. Parkinsonism Relat Disord 18(5):494\u2013500. doi:\n                    10.1016\/j.parkreldis.2012.01.009","journal-title":"Parkinsonism Relat Disord"},{"issue":"Pt 3","key":"1485_CR143","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/brain\/awm302","volume":"131","author":"S Orimo","year":"2008","unstructured":"Orimo S, Uchihara T, Nakamura A, Mori F, Kakita A, Wakabayashi K, Takahashi H (2008) Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson\u2019s disease. Brain 131(Pt 3):642\u2013650. doi:\n                    10.1093\/brain\/awm302","journal-title":"Brain"},{"issue":"4","key":"1485_CR144","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00401-008-0346-6","volume":"115","author":"L Parkkinen","year":"2008","unstructured":"Parkkinen L, Pirttila T, Alafuzoff I (2008) Applicability of current staging\/categorization of alpha-synuclein pathology and their clinical relevance. Acta Neuropathol 115(4):399\u2013407. doi:\n                    10.1007\/s00401-008-0346-6","journal-title":"Acta Neuropathol"},{"issue":"9","key":"1485_CR145","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1016\/j.neurobiolaging.2014.03.024","volume":"35","author":"P Pasanen","year":"2014","unstructured":"Pasanen P, Myllykangas L, Siitonen M, Raunio A, Kaakkola S, Lyytinen J, Tienari PJ, Poyhonen M, Paetau A (2014) Novel alpha-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson\u2019s disease-type pathology. Neurobiol Aging 35(9):2180\u20132185. doi:\n                    10.1016\/j.neurobiolaging.2014.03.024","journal-title":"Neurobiol Aging"},{"key":"1485_CR146","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.nbd.2015.06.003","volume":"82","author":"KL Paumier","year":"2015","unstructured":"Paumier KL, Luk KC, Manfredsson FP, Kanaan NM, Lipton JW, Collier TJ, Steece-Collier K, Kemp CJ, Celano S, Schulz E, Sandoval IM, Fleming S, Dirr E, Polinski NK, Trojanowski JQ, Lee VM, Sortwell CE (2015) Intrastriatal injection of pre-formed mouse alpha-synuclein fibrils into rats triggers alpha-synuclein pathology and bilateral nigrostriatal degeneration. Neurobiol Dis 82:185\u2013199. doi:\n                    10.1016\/j.nbd.2015.06.003","journal-title":"Neurobiol Dis"},{"issue":"7556","key":"1485_CR147","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature14547","volume":"522","author":"W Peelaerts","year":"2015","unstructured":"Peelaerts W, Bousset L, Van der Perren A, Moskalyuk A, Pulizzi R, Giugliano M, Van den Haute C, Melki R, Baekelandt V (2015) Alpha-synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522(7556):340\u2013344. doi:\n                    10.1038\/nature14547","journal-title":"Nature"},{"issue":"1","key":"1485_CR148","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/NEN.0b013e3181c6c13d","volume":"69","author":"M Pikkarainen","year":"2010","unstructured":"Pikkarainen M, Martikainen P, Alafuzoff I (2010) The effect of prolonged fixation time on immunohistochemical staining of common neurodegenerative disease markers. J Neuropathol Exp Neurol 69(1):40\u201352. doi:\n                    10.1097\/NEN.0b013e3181c6c13d","journal-title":"J Neuropathol Exp Neurol"},{"key":"1485_CR149","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fncom.2013.00013","volume":"7","author":"EK Pissadaki","year":"2013","unstructured":"Pissadaki EK, Bolam JP (2013) The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson\u2019s disease. Front Comput Neurosci 7:13. doi:\n                    10.3389\/fncom.2013.00013","journal-title":"Front Comput Neurosci"},{"issue":"5321","key":"1485_CR150","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276(5321):2045\u20132047","journal-title":"Science"},{"issue":"11","key":"1485_CR151","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1212\/WNL.0b013e31828727ba","volume":"80","author":"C Proukakis","year":"2013","unstructured":"Proukakis C, Dudzik CG, Brier T, Mackay DS, Cooper JM, Millhauser GL, Houlden H, Schapira AH (2013) A novel alpha-synuclein missense mutation in Parkinson disease. Neurology 80(11):1062\u20131064. doi:\n                    10.1212\/WNL.0b013e31828727ba","journal-title":"Neurology"},{"issue":"3","key":"1485_CR152","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/ana.24066","volume":"75","author":"A Recasens","year":"2014","unstructured":"Recasens A, Dehay B, Bove J, Carballo-Carbajal I, Dovero S, Perez-Villalba A, Fernagut PO, Blesa J, Parent A, Perier C, Farinas I, Obeso JA, Bezard E, Vila M (2014) Lewy body extracts from Parkinson disease brains trigger alpha-synuclein pathology and neurodegeneration in mice and monkeys. Ann Neurol 75(3):351\u2013362. doi:\n                    10.1002\/ana.24066","journal-title":"Ann Neurol"},{"issue":"4","key":"1485_CR153","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00401-013-1160-3","volume":"126","author":"NL Rey","year":"2013","unstructured":"Rey NL, Petit GH, Bousset L, Melki R, Brundin P (2013) Transfer of human alpha-synuclein from the olfactory bulb to interconnected brain regions in mice. Acta Neuropathol 126(4):555\u2013573. doi:\n                    10.1007\/s00401-013-1160-3","journal-title":"Acta Neuropathol"},{"issue":"3","key":"1485_CR154","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/glia.22611","volume":"62","author":"JF Reyes","year":"2013","unstructured":"Reyes JF, Rey NL, Bousset L, Melki R, Brundin P, Angot E (2013) Alpha-synuclein transfers from neurons to oligodendrocytes. Glia 62(3):387\u2013398. doi:\n                    10.1002\/glia.22611","journal-title":"Glia"},{"issue":"Pt 6","key":"1485_CR155","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1093\/brain\/awv040","volume":"138","author":"RF Roberts","year":"2015","unstructured":"Roberts RF, Wade-Martins R, Alegre-Abarrategui J (2015) Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson\u2019s disease brain. Brain 138(Pt 6):1642\u20131657. doi:\n                    10.1093\/brain\/awv040","journal-title":"Brain"},{"issue":"5B","key":"1485_CR156","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1111\/j.1582-4934.2008.00450.x","volume":"12","author":"C Roodveldt","year":"2008","unstructured":"Roodveldt C, Christodoulou J, Dobson CM (2008) Immunological features of alpha-synuclein in Parkinson\u2019s disease. J Cell Mol Med 12(5B):1820\u20131829","journal-title":"J Cell Mol Med"},{"key":"1485_CR157","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neulet.2015.04.022","volume":"597","author":"NJ Rutherford","year":"2015","unstructured":"Rutherford NJ, Giasson BI (2015) The A53E alpha-synuclein pathological mutation demonstrates reduced aggregation propensity in vitro and in cell culture. Neurosci Lett 597:43\u201348. doi:\n                    10.1016\/j.neulet.2015.04.022","journal-title":"Neurosci Lett"},{"issue":"6","key":"1485_CR158","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/jnc.12806","volume":"131","author":"NJ Rutherford","year":"2014","unstructured":"Rutherford NJ, Moore BD, Golde TE, Giasson BI (2014) Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of alpha-synuclein. J Neurochem 131(6):859\u2013867. doi:\n                    10.1111\/jnc.12806","journal-title":"J Neurochem"},{"issue":"1","key":"1485_CR159","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/2051-5960-1-38","volume":"1","author":"AN Sacino","year":"2013","unstructured":"Sacino AN, Brooks M, McGarvey NH, McKinney AB, Thomas MA, Levites Y, Ran Y, Golde TE, Giasson BI (2013) Induction of CNS alpha-synuclein pathology by fibrillar and non-amyloidogenic recombinant alpha-synuclein. Acta Neuropathol Commun 1(1):38. doi:\n                    10.1186\/2051-5960-1-38","journal-title":"Acta Neuropathol Commun"},{"issue":"37","key":"1485_CR160","doi-asserted-by":"publisher","first-page":"12368","DOI":"10.1523\/JNEUROSCI.2102-14.2014","volume":"34","author":"AN Sacino","year":"2014","unstructured":"Sacino AN, Brooks M, McKinney AB, Thomas MA, Shaw G, Golde TE, Giasson BI (2014) Brain injection of alpha-synuclein induces multiple proteinopathies, gliosis, and a neuronal injury marker. J Neurosci 34(37):12368\u201312378. doi:\n                    10.1523\/JNEUROSCI.2102-14.2014","journal-title":"J Neurosci"},{"issue":"29","key":"1485_CR161","doi-asserted-by":"publisher","first-page":"10732","DOI":"10.1073\/pnas.1321785111","volume":"111","author":"AN Sacino","year":"2014","unstructured":"Sacino AN, Brooks M, Thomas MA, McKinney AB, Lee S, Regenhardt RW, McGarvey NH, Ayers JI, Notterpek L, Borchelt DR, Golde TE, Giasson BI (2014) Intramuscular injection of alpha-synuclein induces CNS alpha-synuclein pathology and a rapid-onset motor phenotype in transgenic mice. Proc Natl Acad Sci USA 111(29):10732\u201310737. doi:\n                    10.1073\/pnas.1321785111","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"1485_CR162","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00401-014-1268-0","volume":"127","author":"AN Sacino","year":"2014","unstructured":"Sacino AN, Brooks M, Thomas MA, McKinney AB, McGarvey NH, Rutherford NJ, Ceballos-Diaz C, Robertson J, Golde TE, Giasson BI (2014) Amyloidogenic alpha-synuclein seeds do not invariably induce rapid, widespread pathology in mice. Acta Neuropathol 127(7):645\u2013665. doi:\n                    10.1007\/s00401-014-1268-0","journal-title":"Acta Neuropathol"},{"key":"1485_CR163","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1750-1326-8-17","volume":"8","author":"AN Sacino","year":"2013","unstructured":"Sacino AN, Thomas MA, Ceballos-Diaz C, Cruz PE, Rosario AM, Lewis J, Giasson BI, Golde TE (2013) Conformational templating of alpha-synuclein aggregates in neuronal-glial cultures. Mol Neurodegener 8:17. doi:\n                    10.1186\/1750-1326-8-17","journal-title":"Mol Neurodegener"},{"key":"1485_CR164","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/BF01483607","volume":"38","author":"I Sano","year":"1960","unstructured":"Sano I, Taniguchi K, Gamo T, Takesada M, Kakimoto Y (1960) Die Katechinamine im Zentralnervensystem. Klinische Wochenschrift 38:57\u201362","journal-title":"Klinische Wochenschrift"},{"issue":"1","key":"1485_CR165","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00401-014-1360-5","volume":"129","author":"M Schweighauser","year":"2015","unstructured":"Schweighauser M, Bacioglu M, Fritschi SK, Shimshek DR, Kahle PJ, Eisele YS, Jucker M (2015) Formaldehyde-fixed brain tissue from spontaneously ill alpha-synuclein transgenic mice induces fatal alpha-synucleinopathy in transgenic hosts. Acta Neuropathol 129(1):157\u2013159. doi:\n                    10.1007\/s00401-014-1360-5","journal-title":"Acta Neuropathol"},{"issue":"9","key":"1485_CR166","doi-asserted-by":"publisher","first-page":"4897","DOI":"10.1073\/pnas.97.9.4897","volume":"97","author":"LC Serpell","year":"2000","unstructured":"Serpell LC, Berriman J, Jakes R, Goedert M, Crowther RA (2000) Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation. Proc Natl Acad Sci USA 97(9):4897\u20134902","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5646","key":"1485_CR167","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K (2003) Alpha-synuclein locus triplication causes Parkinson\u2019s disease. Science 302(5646):841","journal-title":"Science"},{"issue":"6645","key":"1485_CR168","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388(6645):839\u2013840. doi:\n                    10.1038\/42166","journal-title":"Nature"},{"key":"1485_CR169","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","volume":"106\u2013107","author":"SR Subramaniam","year":"2013","unstructured":"Subramaniam SR, Chesselet MF (2013) Mitochondrial dysfunction and oxidative stress in parkinson\u2019s disease. Prog Neurobiol 106\u2013107:17\u201332. doi:\n                    10.1016\/j.pneurobio.2013.04.004","journal-title":"Prog Neurobiol"},{"issue":"1","key":"1485_CR170","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/mds.25095","volume":"28","author":"D Sulzer","year":"2013","unstructured":"Sulzer D, Surmeier DJ (2013) Neuronal vulnerability, pathogenesis, and Parkinson\u2019s disease. Mov Disord 28(1):41\u201350. doi:\n                    10.1002\/mds.25095","journal-title":"Mov Disord"},{"issue":"29","key":"1485_CR171","doi-asserted-by":"publisher","first-page":"27441","DOI":"10.1074\/jbc.M101318200","volume":"276","author":"JY Sung","year":"2001","unstructured":"Sung JY, Kim J, Paik SR, Park JH, Ahn YS, Chung KC (2001) Induction of neuronal cell death by Rab5a-dependent endocytosis of alpha-synuclein. J Biol Chem 276(29):27441\u201327448. doi:\n                    10.1074\/jbc.M101318200","journal-title":"J Biol Chem"},{"issue":"9","key":"1485_CR172","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1136\/jnnp-2015-310686","volume":"86","author":"M Takahashi","year":"2015","unstructured":"Takahashi M, Ikemura M, Oka T, Uchihara T, Wakabayashi K, Kakita A, Takahashi H, Yoshida M, Toru S, Kobayashi T, Orimo S (2015) Quantitative correlation between cardiac MIBG uptake and remaining axons in the cardiac sympathetic nerve in Lewy body disease. J Neurol Neurosurg Psychiatry 86(9):939\u2013944. doi:\n                    10.1136\/jnnp-2015-310686","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"1485_CR173","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.celrep.2014.05.033","volume":"7","author":"HT Tran","year":"2014","unstructured":"Tran HT, Chung CH, Iba M, Zhang B, Trojanowski JQ, Luk KC, Lee VM (2014) Alpha-synuclein immunotherapy blocks uptake and templated propagation of misfolded alpha-synuclein and neurodegeneration. Cell Rep 7(6):2054\u20132065. doi:\n                    10.1016\/j.celrep.2014.05.033","journal-title":"Cell Rep"},{"issue":"5","key":"1485_CR174","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/s00429-013-0651-2","volume":"219","author":"I Ubeda-Banon","year":"2014","unstructured":"Ubeda-Banon I, Saiz-Sanchez D, de la Rosa-Prieto C, Martinez-Marcos A (2014) Alpha-synuclein in the olfactory system in Parkinson\u2019s disease: role of neural connections on spreading pathology. Brain Struct Funct 219(5):1513\u20131526. doi:\n                    10.1007\/s00429-013-0651-2","journal-title":"Brain Struct Funct"},{"issue":"5","key":"1485_CR175","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00401-007-0200-2","volume":"113","author":"T Uchihara","year":"2007","unstructured":"Uchihara T (2007) Silver diagnosis in neuropathology: principles, practice and revised interpretation. Acta Neuropathol 113(5):483\u2013499. doi:\n                    10.1007\/s00401-007-0200-2","journal-title":"Acta Neuropathol"},{"issue":"7","key":"1485_CR176","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/emmm.201302475","volume":"5","author":"A Ulusoy","year":"2013","unstructured":"Ulusoy A, Rusconi R, Perez-Revuelta BI, Musgrove RE, Helwig M, Winzen-Reichert B, Di Monte DA (2013) Caudo-rostral brain spreading of alpha-synuclein through vagal connections. EMBO Mol Med 5(7):1051\u20131059. doi:\n                    10.1002\/emmm.201302475","journal-title":"EMBO Mol Med"},{"issue":"14","key":"1485_CR177","doi-asserted-by":"publisher","first-page":"10737","DOI":"10.1074\/jbc.M010907200","volume":"276","author":"VN Uversky","year":"2001","unstructured":"Uversky VN, Li J, Fink AL (2001) Evidence for a partially-folded intermediate in alpha-synuclein fibril formation. J Biol Chem 276(14):10737\u201310744","journal-title":"J Biol Chem"},{"issue":"11","key":"1485_CR178","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S1474-4422(11)70213-7","volume":"10","author":"K Vekrellis","year":"2011","unstructured":"Vekrellis K, Xilouri M, Emmanouilidou E, Rideout HJ, Stefanis L (2011) Pathological roles of alpha-synuclein in neurological disorders. Lancet Neurol 10(11):1015\u20131025. doi:\n                    10.1016\/S1474-4422(11)70213-7","journal-title":"Lancet Neurol"},{"issue":"1","key":"1485_CR179","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","volume":"72","author":"LA Volpicelli-Daley","year":"2011","unstructured":"Volpicelli-Daley LA, Luk KC, Patel TP, Tanik SA, Riddle DM, Stieber A, Meaney DF, Trojanowski JQ, Lee VM (2011) Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72(1):57\u201371. doi:\n                    10.1016\/j.neuron.2011.08.033","journal-title":"Neuron"},{"issue":"1","key":"1485_CR180","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-010-0706-x","volume":"120","author":"K Wakabayashi","year":"2010","unstructured":"Wakabayashi K, Mori F, Tanji K, Orimo S, Takahashi H (2010) Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain. Acta Neuropathol 120(1):1\u201312. doi:\n                    10.1007\/s00401-010-0706-x","journal-title":"Acta Neuropathol"},{"issue":"3","key":"1485_CR181","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.nbd.2005.06.005","volume":"20","author":"J Wang","year":"2005","unstructured":"Wang J, Xu G, Slunt HH, Gonzales V, Coonfield M, Fromholt D, Copeland NG, Jenkins NA, Borchelt DR (2005) Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA. Neurobiol Dis 20(3):943\u2013952. doi:\n                    10.1016\/j.nbd.2005.06.005","journal-title":"Neurobiol Dis"},{"issue":"3","key":"1485_CR182","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3233\/JPD-130279","volume":"4","author":"ZY Wang","year":"2014","unstructured":"Wang ZY, Lian H, Cai QQ, Song HY, Zhang XL, Zhou L, Zhang YM, Zheng LF, Zhu JX (2014) No direct projection is observed from the substantia nigra to the dorsal vagus complex in the rat. J Parkinsons Dis 4(3):375\u2013383. doi:\n                    10.3233\/JPD-130279","journal-title":"J Parkinsons Dis"},{"issue":"10","key":"1485_CR183","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.tins.2013.06.007","volume":"36","author":"JD Warren","year":"2013","unstructured":"Warren JD, Rohrer JD, Schott JM, Fox NC, Hardy J, Rossor MN (2013) Molecular nexopathies: a new paradigm of neurodegenerative disease. Trends Neurosci 36(10):561\u2013569. doi:\n                    10.1016\/j.tins.2013.06.007","journal-title":"Trends Neurosci"},{"issue":"48","key":"1485_CR184","doi-asserted-by":"publisher","first-page":"19555","DOI":"10.1073\/pnas.1318268110","volume":"110","author":"JC Watts","year":"2013","unstructured":"Watts JC, Giles K, Oehler A, Middleton L, Dexter DT, Gentleman SM, DeArmond SJ, Prusiner SB (2013) Transmission of multiple system atrophy prions to transgenic mice. Proc Natl Acad Sci USA 110(48):19555\u201319560. doi:\n                    10.1073\/pnas.1318268110","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1485_CR185","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00401-008-0375-1","volume":"116","author":"EA Waxman","year":"2008","unstructured":"Waxman EA, Duda JE, Giasson BI (2008) Characterization of antibodies that selectively detect alpha-synuclein in pathological inclusions. Acta Neuropathol 116(1):37\u201346","journal-title":"Acta Neuropathol"},{"key":"1485_CR186","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.bbadis.2008.09.013","volume":"1792","author":"EA Waxman","year":"2008","unstructured":"Waxman EA, Giasson BI (2008) Molecular mechanisms of alpha-synuclein neurodegeneration. Biochim Biophys Acta 1792:616\u2013624","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"1485_CR187","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/NEN.0b013e3186fc995","volume":"67","author":"EA Waxman","year":"2008","unstructured":"Waxman EA, Giasson BI (2008) Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein. J Neuropathol Exp Neurol 67(5):402\u2013416","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"1485_CR188","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1471-4159.2010.06592.x","volume":"113","author":"EA Waxman","year":"2010","unstructured":"Waxman EA, Giasson BI (2010) A novel, high-efficiency cellular model of fibrillar alpha-synuclein inclusions and the examination of mutations that inhibit amyloid formation. J Neurochem 113(2):374\u2013388","journal-title":"J Neurochem"},{"issue":"40","key":"1485_CR189","doi-asserted-by":"publisher","first-page":"9427","DOI":"10.1021\/bi900539p","volume":"48","author":"EA Waxman","year":"2009","unstructured":"Waxman EA, Mazzulli JR, Giasson BI (2009) Characterization of hydrophobic residue requirements for alpha-synuclein fibrillization. Biochemistry 48(40):9427\u20139436. doi:\n                    10.1021\/bi900539p","journal-title":"Biochemistry"},{"issue":"3","key":"1485_CR190","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0165-0173(80)90009-0","volume":"2","author":"KN Westlund","year":"1980","unstructured":"Westlund KN, Coulter JD (1980) Descending projections of the locus coeruleus and subcoeruleus\/medial parabrachial nuclei in monkey: axonal transport studies and dopamine-beta-hydroxylase immunocytochemistry. Brain Res 2(3):235\u2013264","journal-title":"Brain Res"},{"issue":"28","key":"1485_CR191","doi-asserted-by":"publisher","first-page":"19509","DOI":"10.1074\/jbc.274.28.19509","volume":"274","author":"SJ Wood","year":"1999","unstructured":"Wood SJ, Wypych J, Steavenson S, Louis JC, Citron M, Biere AL (1999) Alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson\u2019s disease. J Biol Chem 274(28):19509\u201319512","journal-title":"J Biol Chem"},{"issue":"2","key":"1485_CR192","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s12035-012-8341-2","volume":"47","author":"M Xilouri","year":"2013","unstructured":"Xilouri M, Brekk OR, Stefanis L (2013) Alpha-synuclein and protein degradation systems: a reciprocal relationship. Mol Neurobiol 47(2):537\u2013551. doi:\n                    10.1007\/s12035-012-8341-2","journal-title":"Mol Neurobiol"},{"issue":"1","key":"1485_CR193","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1440-1789.2006.00736.x","volume":"27","author":"O Yokota","year":"2007","unstructured":"Yokota O, Tsuchiya K, Uchihara T, Ujike H, Terada S, Takahashi M, Kimura Y, Ishizu H, Akiyama H, Kuroda S (2007) Lewy body variant of Alzheimer\u2019s disease or cerebral type Lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem. Neuropathology 27(1):21\u201335","journal-title":"Neuropathology"},{"issue":"2","key":"1485_CR194","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atares B, Llorens V, Gomez TE, del Ser T, Munoz DG, de Yebenes JG (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55(2):164\u2013173","journal-title":"Ann Neurol"},{"issue":"6","key":"1485_CR195","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1096\/fj.04-2751com","volume":"19","author":"W Zhang","year":"2005","unstructured":"Zhang W, Wang T, Pei Z, Miller DS, Wu X, Block ML, Wilson B, Zhang W, Zhou Y, Hong JS, Zhang J (2005) Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson\u2019s disease. FASEB J 19(6):533\u2013542","journal-title":"FASEB J"},{"issue":"19","key":"1485_CR196","doi-asserted-by":"publisher","first-page":"16873","DOI":"10.1074\/jbc.M210136200","volume":"278","author":"M Zhu","year":"2003","unstructured":"Zhu M, Fink AL (2003) Lipid binding inhibits alpha-synuclein fibril formation. J Biol Chem 278(19):16873\u201316877. doi:\n                    10.1074\/jbc.M210136200","journal-title":"J Biol Chem"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-015-1485-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-015-1485-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-015-1485-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-015-1485-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T08:39:50Z","timestamp":1589618390000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-015-1485-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,7]]},"references-count":196,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["1485"],"URL":"https:\/\/doi.org\/10.1007\/s00401-015-1485-1","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725840309.793535762","asserted-by":"object"}]},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,7]]},"assertion":[{"value":"3 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}